Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/02/2011 | EP2195013B1 Therapeutic use of a growth factor, metrnl |
11/02/2011 | EP1966208B1 (1-AZA-BICYCLO[3.3.1]NON-4-YL)-[5-(1H-INDOL-5-YL)-HETEROARYL]-AMINES AS CHOLINERGIC LIGANDS OF THE N-AChR FOR THE TREATMENT OF PSYCHOTIC AND NEURODEGENERATIVE DISORDERS |
11/02/2011 | EP1960387B1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor |
11/02/2011 | CN1981752B Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine |
11/02/2011 | CN102232075A Amino pyrazole compound |
11/02/2011 | CN102232074A Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
11/02/2011 | CN102232072A (R)-3-(E)-2-(pyrr0lidin-3-yl) vinyl)-5-(tetrahydr0pyran-4-yl0xy) pyridine, its salts, its synthesis and its use as ligand for nicotinic acetylcholinergic receptors |
11/02/2011 | CN102232070A Synthesis and novel salt forms of (R)-5-((E)-2-(pyrrolidin-3-ylvinyl)pyrimidine |
11/02/2011 | CN102229668A GLP-1 (glucagon-like peptide-1) derivative and application thereof |
11/02/2011 | CN102229651A Amyloid protein intra-membrane segment for treating Alzheimer disease and application thereof |
11/02/2011 | CN102229606A 2-methylbenzofuran derivative containing isoxazole heterocycle, and preparation method and application thereof |
11/02/2011 | CN102229603A Triazole heterocycle-containing 2-methyl benzofuran compound, and preparation and application thereof |
11/02/2011 | CN102229602A Tacrine heterocomplex, preparation method and use in medicines for curing neurodegenerative diseases thereof |
11/02/2011 | CN102229580A Novel pleuromutilin derivate, preparation method and medical use thereof |
11/02/2011 | CN102229566A Structure of drug for treating neurodegenerative disease |
11/02/2011 | CN102229562A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
11/02/2011 | CN102229528A Method for extracting unsaturated fatty acid composition from humen amniotic epithelial cells, and application thereof |
11/02/2011 | CN102228667A External medicinal plaster for treating facial paralysis and preparation method thereof |
11/02/2011 | CN102228659A Chinese medicinal composition for treating generalized anxiety disorder and preparation method thereof |
11/02/2011 | CN102228653A Ethanol extract of galangal fruit and medical application thereof |
11/02/2011 | CN102228639A Medicine for treating vertigo |
11/02/2011 | CN102228617A Medicinal composition for treating insomnia |
11/02/2011 | CN102228579A Medicament for treating prosopalgia |
11/02/2011 | CN102228567A Medicine for treating trigeminal neuralgia |
11/02/2011 | CN102228516A Medicine for treating headache due to pathogenic wind-heat |
11/02/2011 | CN102228505A Chinese medicinal composition with effects of nourishing heart and tranquilizing mind and preparation method and detection method thereof |
11/02/2011 | CN102228497A Processing method of chrysanthemum |
11/02/2011 | CN102228484A Chinese medicinal preparation Jinshuibao oral liquid and preparation method thereof |
11/02/2011 | CN102228467A Application of hydrogen physiological saline in preparation for medicine treating acute neurological damage diseases |
11/02/2011 | CN102228457A Pharmaceutical composition for treating diabetes and complication thereof |
11/02/2011 | CN102228456A Novel * ketone compound and its protection effect on nerve cell |
11/02/2011 | CN102228454A Brain targeting via olfactory pathway fragrant essential oil compound and monomer pharmaceutical composition with functions for preventing and treating brain atrophy and activating brain cells |
11/02/2011 | CN102228452A Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof |
11/02/2011 | CN102228449A Gastrodin chronopharmaceutical medicine delivery preparation |
11/02/2011 | CN102228428A Large volume injection composition containing vinpocetine and preparation method thereof |
11/02/2011 | CN101732492B Adinandra nitida leaf flavone oral tablet and preparation method |
11/02/2011 | CN101700294B Oral traditional Chinese medicine decoction for treating migraine |
11/02/2011 | CN101642540B Chinese patent medicine for tranquilizing and allaying excitement |
11/02/2011 | CN101549017B Traditional Chinese medicine composition for treating arrhythmia and preparation method thereof |
11/02/2011 | CN101547692B Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
11/02/2011 | CN101516887B Thiazole pyrazolopyrimidines as crf1 receptor antagonists |
11/02/2011 | CN101336656B Brain nourishing, intelligence benefiting and healthy noodle capable of activating brain cell and production method thereof |
11/02/2011 | CN101301310B Use of brown alga polysaccharide sulfate in preventing and treating Parkinson's disease |
11/02/2011 | CN101190208B Medicinal preparations containing duloxetine hydrochloride and preparation method thereof |
11/02/2011 | CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
11/01/2011 | US8048918 Treatment of hyperproliferative diseases |
11/01/2011 | US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
11/01/2011 | US8048876 Process for preparing quetiapine and quetiapine fumarate |
11/01/2011 | US8048874 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
11/01/2011 | US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use |
11/01/2011 | CA2697570C Reduced volume formulation of glatiramer acetate and methods of administration |
11/01/2011 | CA2663408C Substituted pyridylmethyl bicyclocarboxyamide compounds |
11/01/2011 | CA2661759C Buprenophine-wafer for drug substitution therapy |
11/01/2011 | CA2629462C Beta-secretase modulators and methods of use |
11/01/2011 | CA2530487C Methods of preventing and reducing the severity of stress-associated conditions |
11/01/2011 | CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy |
11/01/2011 | CA2490254C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
11/01/2011 | CA2488834C Purine derivatives and their use as antiproliferative agents |
11/01/2011 | CA2476683C Partial and full agonists of a1 adenosine receptors |
11/01/2011 | CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
11/01/2011 | CA2468826C Benzazole derivatives for the treatment of scleroderma |
11/01/2011 | CA2466418C Lipoxin a4 analogs |
11/01/2011 | CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases |
11/01/2011 | CA2452986C Use of polyclonal anti-hiv goat serum as a therapeutic agent |
11/01/2011 | CA2448094C Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
11/01/2011 | CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
11/01/2011 | CA2439269C Pharmaceutical salts of 1-phenyl-3-dimethylaminopropane compounds |
11/01/2011 | CA2434526C Methods of administering epothilone analogs for the treatment of cancer |
11/01/2011 | CA2400543C The involvement of the bdnf gene in mood disorders |
11/01/2011 | CA2375910C Tanacetum parthenium extract |
11/01/2011 | CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide |
10/27/2011 | WO2011133893A2 Cyanide antidotes |
10/27/2011 | WO2011133661A2 Methods and compositions related to dopaminergic neuronal cells |
10/27/2011 | WO2011133637A2 Compounds and methods for kinase modulation, and indications therefor |
10/27/2011 | WO2011133182A1 Modulators of 5-ht receptors and methods of use thereof |
10/27/2011 | WO2011132966A2 Transdermal absorption preparation |
10/27/2011 | WO2011132831A1 Use of glutamine for prevention, treatment or diagnosis of depression |
10/27/2011 | WO2011132435A1 Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same |
10/27/2011 | WO2011132048A1 Heteroaryl compounds as pde10a inhibitors |
10/27/2011 | WO2011131896A2 Peptide derivatives, preparation thereof and uses thereof as vectors |
10/27/2011 | WO2011131748A2 Novel inhibitors |
10/27/2011 | WO2011131661A1 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis |
10/27/2011 | WO2011131571A1 Pyrrazolopyridine derivatives |
10/27/2011 | WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof |
10/27/2011 | WO2011130834A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof |
10/27/2011 | WO2011101881A3 Use of rho gtpase activating toxins for the treatment and/or prevention symptomatology associated with rett syndrome |
10/27/2011 | WO2011087713A3 Substituted hexahydrochromeno [3, 4 - b] pyrroles with affinity for the serotonin receptor (5-ht) family |
10/27/2011 | WO2011069032A3 Formulations, salts and polymorphs of transnorsertraline and uses thereof |
10/27/2011 | WO2011066182A3 Socs3 inhibition promotes cns neuron regeneration |
10/27/2011 | WO2011059779A3 Ligand-targeted multi- stereoisomer peptide polymer conjugates and uses thereof |
10/27/2011 | WO2011059207A3 Arylpiperazine-containing purine derivatives and uses thereof |
10/27/2011 | WO2011056985A3 Substituted heterocyclic compounds |
10/27/2011 | WO2011056773A3 Inhibiting neurotransmitter reuptake |
10/27/2011 | WO2011046622A3 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
10/27/2011 | US20110263968 Drug-Enhanced Neurofeedback |
10/27/2011 | US20110263721 Aryl di-substituted propenone compounds |
10/27/2011 | US20110263720 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
10/27/2011 | US20110263719 Polymorphic form of rasagiline mesylate |
10/27/2011 | US20110263718 Process for the preparation of o-desmethylvenlafaxine |
10/27/2011 | US20110263711 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis |